How to buy Radius Health stock | $15.96

Radius Health Inc is a drug manufacturers-specialty & generic business based in the US. Radius Health shares (RDUS) are listed on the NASDAQ and all prices are listed in US Dollars. Radius Health employs 310 staff and has a trailing 12-month revenue of around 0.00.

Radius Health stock price (NASDAQ: RDUS)

Use our graph to track the performance of RDUS stocks over time.

Radius Health shares at a glance

• Key figures

Information last updated 2021-10-16.

Latest market close	$15.96
52-week range	$11.95 - $25.82
50-day moving average	$13.21
200-day moving average	$16.91
Wall St. target price	$22.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.29

Buy Radius Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Radius Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Radius Health price performance over time

Historical closes compared with the close of $15.96 from 2021-10-18

1 week (2021-10-12)	7.98%
1 month (2021-09-17)	24.69%
3 months (2021-07-19)	-2.21%
6 months (2021-04-19)	-15.56%

1 year (2020-10-19)	19.73%
2 years (2019-10-18)	-41.56%
3 years (2018-10-19)	18.96
5 years (2016-10-19)	51.02

Radius Health financials

Revenue TTM	$248.7 million
Gross profit TTM	$222.2 million
Return on assets TTM	-13.2%
Return on equity TTM	0%
Profit margin	-24.22%
Book value	$0.00
Market capitalisation	$713.7 million

TTM: trailing 12 months

Shorting Radius Health shares

There are currently 4.6 million Radius Health shares held short by investors – that's known as Radius Health's "short interest". This figure is 6% down from 4.8 million last month.

There are a few different ways that this level of interest in shorting Radius Health shares can be evaluated.

Radius Health's "short interest ratio" (SIR)

Radius Health's "short interest ratio" (SIR) is the quantity of Radius Health shares currently shorted divided by the average quantity of Radius Health shares traded daily (recently around 368767.53036437). Radius Health's SIR currently stands at 12.35. In other words for every 100,000 Radius Health shares traded daily on the market, roughly 12350 shares are currently held short.

However Radius Health's short interest can also be evaluated against the total number of Radius Health shares, or, against the total number of tradable Radius Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Radius Health's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Radius Health shares in existence, roughly 100 shares are currently held short) or 0.0974% of the tradable shares (for every 100,000 tradable Radius Health shares, roughly 97 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Radius Health.

Find out more about how you can short Radius Health stock.

Radius Health share dividends

We're not expecting Radius Health to pay a dividend over the next 12 months.

Have Radius Health's shares ever split?

Radius Health's shares were split on a 25:57 basis on 23 April 2014. So if you had owned 57 shares the day before before the split, the next day you'd have owned 25 shares. This wouldn't directly have changed the overall worth of your Radius Health shares – just the quantity. However, indirectly, the new 128% higher share price could have impacted the market appetite for Radius Health shares which in turn could have impacted Radius Health's share price.

Radius Health share price volatility

Over the last 12 months, Radius Health's shares have ranged in value from as little as $11.95 up to $25.82. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Radius Health's is 0.9354. This would suggest that Radius Health's shares are less volatile than average (for this exchange).

Radius Health overview

Radius Health, Inc. , a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd. ; and Duke University.

Frequently asked questions

What percentage of Radius Health is owned by insiders or institutions?
Currently 1.056% of Radius Health shares are held by insiders and 106.542% by institutions. How many people work for Radius Health?
Latest data suggests 310 work at Radius Health. When does the fiscal year end for Radius Health?
Radius Health's fiscal year ends in December. Where is Radius Health based?
Radius Health's address is: 22 Boston Wharf Road, Boston, MA, United States, 02210 What is Radius Health's ISIN number?
Radius Health's international securities identification number is: US7504692077 What is Radius Health's CUSIP number?
Radius Health's Committee on Uniform Securities Identification Procedures number is: 750469207